Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 61,561 Shares of Danaher Corporation $DHR

Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 59.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 164,933 shares of the conglomerate’s stock after buying an additional 61,561 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Danaher were worth $31,271,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. Bank Pictet & Cie Europe AG grew its stake in shares of Danaher by 25.4% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after acquiring an additional 74,301 shares during the last quarter. Maxi Investments CY Ltd purchased a new position in shares of Danaher in the 3rd quarter worth about $3,251,000. Northwestern Mutual Wealth Management Co. boosted its stake in Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares in the last quarter. Defender Capital LLC. bought a new position in Danaher in the 4th quarter worth about $35,715,000. Finally, CIBC Bancorp USA Inc. purchased a new stake in Danaher during the 3rd quarter valued at about $17,480,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $197.85 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The firm has a market cap of $140.03 billion, a price-to-earnings ratio of 38.27, a price-to-earnings-growth ratio of 2.47 and a beta of 0.79. The business has a 50-day simple moving average of $178.74 and a two-hundred day simple moving average of $200.56. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter last year, the firm posted $1.88 EPS. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, analysts expect that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio is 30.95%.

Analyst Ratings Changes

A number of research firms have weighed in on DHR. Evercore raised their price objective on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. Weiss Ratings cut shares of Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Guggenheim decreased their price objective on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Finally, DZ Bank began coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Check Out Our Latest Stock Analysis on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.